Related Experiment Video
Updated: Jun 11, 2026

08:53
A Reporter Based Cellular Assay for Monitoring Splicing Efficiency
Published on: September 15, 2021
The 20S proteasome splicing activity discovered by SpliceMet
Juliane Liepe1, Michele Mishto, Kathrin Textoris-Taube
1Institut für Biochemie, Charité, Universitätsmedizin Berlin, Berlin, Germany.
Plos Computational Biology
|July 9, 2010
Summary
Researchers developed SpliceMet to identify proteasome-generated spliced peptides (PSP), revealing new insights into proteasome-catalyzed peptide splicing (PCPS) and the 20S proteasome
Area of Science:
- Proteomics
- Molecular Biology
- Immunology
Background:
- Proteasome-generated spliced peptides (PSP) indicate novel protease activity but their characterization is limited.
- Previous PSP studies relied on patient-derived cytotoxic T lymphocytes (CTL), hindering systematic investigation.
- Proteasome-catalyzed peptide splicing (PCPS) requires new methodologies for comprehensive analysis.
Purpose of the Study:
- To develop a method for unrestricted identification of proteasome-generated spliced peptides (PSP).
- To systematically investigate proteasome-catalyzed peptide splicing (PCPS) independent of patient samples.
- To characterize novel spliced peptides generated by the 20S proteasome.
Main Methods:
- Development of SpliceMet, integrating the ProteaJ algorithm with in vitro proteasomal degradation and mass spectrometry.
- Analysis of proteasomal processing products from four distinct substrate polypeptides (human tumor and viral antigens).
- Identification of cis- and trans-spliced peptides generated by PCPS.
Main Results:
- SpliceMet enabled the identification of fifteen novel spliced peptides.
- These peptides were generated by PCPS through cis-splicing or trans-splicing from separate substrates.
- Demonstrated the capability of 20S proteasomes to produce spliced peptides from various antigens.
Conclusions:
- The 20S proteasome acts as a molecular machine facilitating spliced peptide generation.
- PCPS produces a diverse pool of novel peptides with potential functional relevance.
- SpliceMet provides a powerful tool for systematic PSP and PCPS research.
Related Concept Videos
RNA Splicing
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
RNA Splicing
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
Pre-mRNA Processing: RNA Splicing
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
